Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production
Details for Australian Patent Application No. 2006331950 (hide)
International Classifications
Event Publications
26 June 2008 PCT application entered the National Phase
PCT publication WO2007/075605 Priority application(s): WO2007/075605
10 July 2008 Amendment Made
The nature of the amendment is: Amend the invention title to read: Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance of type 1 and type 2 cytokine production
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006331963-Substituted piperidines as calcium channel blockers
2006331947-Methods for assessing the proinflammatory immune health of an individual
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser